HJ Research delivers in-depth insights on the global Next-Generation Biologics market in its upcoming report titled, Global Next-Generation Biologics Market Report 2018-2029. According to this study, the global Next-Generation Biologics market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Next-Generation Biologics market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Next-Generation Biologics market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Next-Generation Biologics industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Next-Generation Biologics industry.
Global Next-Generation Biologics market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Next-Generation Biologics industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Next-Generation Biologics market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Next-Generation Biologics. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Next-Generation Biologics market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Next-Generation Biologics in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Next-Generation Biologics market include:
Allergan
Bayer
Biogen Idec
Eli Lilly
Kyowa Hakko Kirin
Molecular Partners
Novo Nordisk
Pfizer
Roche
Sanofi
Market segmentation, by product types:
Antibodies
Regenerative medicine
Insulins
Growth hormones
Other
Market segmentation, by applications:
Medical
Scientific Research
Other
1 Industry Overview of Next-Generation Biologics
1.1 Research Scope
1.2 Market Segmentation by Types of Next-Generation Biologics
1.3 Market Segmentation by End Users of Next-Generation Biologics
1.4 Market Dynamics Analysis of Next-Generation Biologics
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Next-Generation Biologics Industry
2.1 Allergan
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Bayer
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Biogen Idec
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Eli Lilly
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Kyowa Hakko Kirin
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Molecular Partners
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Novo Nordisk
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Pfizer
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Roche
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Sanofi
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Next-Generation Biologics Revenue and Gross Margin (2018-2023)
2.10.4 Contact Information
3 Global Next-Generation Biologics Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Next-Generation Biologics by Regions (2018-2023)
3.2 Global Sales Revenue of Next-Generation Biologics by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Next-Generation Biologics by Types (2018-2023)
3.4 Global Sales Revenue of Next-Generation Biologics by End Users (2018-2023)
4 Northern America Next-Generation Biologics Market Analysis by Countries, Types and End Users
4.1 Northern America Next-Generation Biologics Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Next-Generation Biologics Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Next-Generation Biologics Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Next-Generation Biologics Sales Revenue Analysis (2018-2023)
4.5 Canada Next-Generation Biologics Sales Revenue Analysis (2018-2023)
5 Europe Next-Generation Biologics Market Analysis by Countries, Types and End Users
5.1 Europe Next-Generation Biologics Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Next-Generation Biologics Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Next-Generation Biologics Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Next-Generation Biologics Sales Revenue Analysis (2018-2023)
5.5 France Next-Generation Biologics Sales Revenue Analysis (2018-2023)
5.6 UK Next-Generation Biologics Sales Revenue Analysis (2018-2023)
5.7 Italy Next-Generation Biologics Sales Revenue Analysis (2018-2023)
5.8 Russia Next-Generation Biologics Sales Revenue Analysis (2018-2023)
5.9 Spain Next-Generation Biologics Sales Revenue Analysis (2018-2023)
5.10 Netherlands Next-Generation Biologics Sales Revenue Analysis (2018-2023)
6 Asia Pacific Next-Generation Biologics Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Next-Generation Biologics Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Next-Generation Biologics Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Next-Generation Biologics Sales Revenue Analysis by End Users (2018-2023)
6.4 China Next-Generation Biologics Sales Revenue Analysis (2018-2023)
6.5 Japan Next-Generation Biologics Sales Revenue Analysis (2018-2023)
6.6 Korea Next-Generation Biologics Sales Revenue Analysis (2018-2023)
6.7 India Next-Generation Biologics Sales Revenue Analysis (2018-2023)
6.8 Australia Next-Generation Biologics Sales Revenue Analysis (2018-2023)
6.9 Indonesia Next-Generation Biologics Sales Revenue Analysis (2018-2023)
6.10 Vietnam Next-Generation Biologics Sales Revenue Analysis (2018-2023)
7 Latin America Next-Generation Biologics Market Analysis by Countries, Types and End Users
7.1 Latin America Next-Generation Biologics Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Next-Generation Biologics Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Next-Generation Biologics Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Next-Generation Biologics Sales Revenue Analysis (2018-2023)
7.5 Mexico Next-Generation Biologics Sales Revenue Analysis (2018-2023)
7.6 Argentina Next-Generation Biologics Sales Revenue Analysis (2018-2023)
7.7 Colombia Next-Generation Biologics Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Next-Generation Biologics Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Next-Generation Biologics Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Next-Generation Biologics Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Next-Generation Biologics Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Next-Generation Biologics Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Next-Generation Biologics Sales Revenue Analysis (2018-2023)
8.6 South Africa Next-Generation Biologics Sales Revenue Analysis (2018-2023)
8.7 Egypt Next-Generation Biologics Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Next-Generation Biologics Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Next-Generation Biologics by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Next-Generation Biologics by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Next-Generation Biologics by End Users (2024-2029)
10.4 Global Revenue Forecast of Next-Generation Biologics by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Next-Generation Biologics
11.1 Upstream Analysis of Next-Generation Biologics
11.2 Downstream Major Consumers Analysis of Next-Generation Biologics
11.3 Major Suppliers of Next-Generation Biologics with Contact Information
11.4 Supply Chain Relationship Analysis of Next-Generation Biologics
12 Next-Generation Biologics New Project Investment Feasibility Analysis
12.1 Next-Generation Biologics New Project SWOT Analysis
12.2 Next-Generation Biologics New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Next-Generation Biologics Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Next-Generation Biologics
Table End Users of Next-Generation Biologics
Figure Market Drivers Analysis of Next-Generation Biologics
Figure Market Challenges Analysis of Next-Generation Biologics
Figure Market Opportunities Analysis of Next-Generation Biologics
Table Market Drivers Analysis of Next-Generation Biologics
Table Allergan Information List
Figure Next-Generation Biologics Specifications of Allergan
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Allergan (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Allergan (2018-2023)
Table Bayer Information List
Figure Next-Generation Biologics Specifications of Bayer
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Bayer (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Bayer (2018-2023)
Table Biogen Idec Information List
Figure Next-Generation Biologics Specifications of Biogen Idec
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Biogen Idec (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Biogen Idec (2018-2023)
Table Eli Lilly Information List
Figure Next-Generation Biologics Specifications of Eli Lilly
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Eli Lilly (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Eli Lilly (2018-2023)
Table Kyowa Hakko Kirin Information List
Figure Next-Generation Biologics Specifications of Kyowa Hakko Kirin
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Kyowa Hakko Kirin (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Kyowa Hakko Kirin (2018-2023)
Table Molecular Partners Information List
Figure Next-Generation Biologics Specifications of Molecular Partners
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Molecular Partners (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Molecular Partners (2018-2023)
Table Novo Nordisk Information List
Figure Next-Generation Biologics Specifications of Novo Nordisk
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Novo Nordisk (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Novo Nordisk (2018-2023)
Table Pfizer Information List
Figure Next-Generation Biologics Specifications of Pfizer
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Pfizer (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Pfizer (2018-2023)
Table Roche Information List
Figure Next-Generation Biologics Specifications of Roche
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Roche (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Roche (2018-2023)
Table Sanofi Information List
Figure Next-Generation Biologics Specifications of Sanofi
Table Next-Generation Biologics Revenue (Million USD) and Gross Margin of Sanofi (2018-2023)
Figure Next-Generation Biologics Revenue (Million USD) and Global Market Share of Sanofi (2018-2023)
Table Global Revenue (Million USD) of Next-Generation Biologics by Regions (2018-2023)
Table Global Revenue (Million USD) of Next-Generation Biologics by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Next-Generation Biologics by Types (2018-2023)
Table Global Revenue (Million USD) of Next-Generation Biologics by End Users (2018-2023)
Table Northern America Next-Generation Biologics Revenue (Million USD) by Countries (2018-2023)
Table Northern America Next-Generation Biologics Revenue (Million USD) by Types (2018-2023)
Table Northern America Next-Generation Biologics Revenue (Million USD) by End Users (2018-2023)
Figure United States Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Next-Generation Biologics Revenue (Million USD) by Countries (2018-2023)
Table Europe Next-Generation Biologics Revenue (Million USD) by Types (2018-2023)
Table Europe Next-Generation Biologics Revenue (Million USD) by End Users (2018-2023)
Figure Germany Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Next-Generation Biologics Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Next-Generation Biologics Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Next-Generation Biologics Revenue (Million USD) by End Users (2018-2023)
Figure China Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Next-Generation Biologics Revenue (Million USD) by Countries (2018-2023)
Table Latin America Next-Generation Biologics Revenue (Million USD) by Types (2018-2023)
Table Latin America Next-Generation Biologics Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Next-Generation Biologics Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Next-Generation Biologics Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Next-Generation Biologics Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Next-Generation Biologics Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Next-Generation Biologics by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Next-Generation Biologics by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Next-Generation Biologics by End Users (2024-2029)
Table Major Consumers with Contact Information of Next-Generation Biologics
Table Major Suppliers of Next-Generation Biologics with Contact Information
Figure Supply Chain Relationship Analysis of Next-Generation Biologics
Table New Project SWOT Analysis of Next-Generation Biologics
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Next-Generation Biologics
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Next-Generation Biologics Industry
Table Part of References List of Next-Generation Biologics Industry
Table Units of Measurement List
Table Part of Author Details List of Next-Generation Biologics Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Next-Generation Biologics industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Next-Generation Biologics market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Next-Generation Biologics manufacturers, Next-Generation Biologics raw material suppliers, Next-Generation Biologics distributors as well as buyers. The primary sources from the supply side include Next-Generation Biologics manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Next-Generation Biologics raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Next-Generation Biologics industry landscape and trends, Next-Generation Biologics market dynamics and key issues, Next-Generation Biologics technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Next-Generation Biologics competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Next-Generation Biologics market size and forecast by regions, Next-Generation Biologics market size and forecast by application, Next-Generation Biologics market size and forecast by types, Next-Generation Biologics company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
